Forty Seven, Inc.

Forty Seven is a biotechnology company that discovers and develops immuno-oncology therapies for the treatment of cancer.

Business Model:

Revenue: $15.7M

Employees: 51-200

Detailed Forty Seven, Inc. Information

Forty Seven, Inc. was acquired by Gilead Sciences.
The acquisition happend on 2020-03-02.
Details of the transaction were not public

Acquirer

Geographic Data

Forty Seven, Inc. headquarters map

Address: 1490 O'Brien Drive

City: Menlo Park

State: CA

Zip: 94025

Country: US

Financial Info

Stage:

post ipo equity

Raised Last:

$6M

Raised Total:

$156M

Metrics

4,804,174Website Global Rank

1,788Website Monthly Traffic

Twitter Followers

Description

Forty Seven is a biotechnology company that discovers and develops immuno-oncology therapies for the treatment of cancer.

Contact Phone:
+16503524150

Contact Email:

Forty Seven, Inc. went public on 6/27/2018 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
6/27/2018

IPO Valuation:
$479M

Ticker Symbol:
FTSV

IPO Price:
$16/share

Amount Raised:
$112M

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research